Screening

Guidelines and Consensus on Screening and Treatment of Tardive Dyskinesia

Download:

1 to 3-min read

FAST FACTS: GUIDELINES AND CONSENSUS ON SCREENING AND TREATMENT OF TARDIVE DYSKINESIA
This piece was sponsored and co-developed by Neurocrine Biosciences. The faculty have been compensated by Neurocrine Biosciences. This piece is intended to provide general information about tardive dyskinesia and not medical advice for any particular patient.
©2022 Neurocrine Biosciences, Inc. All Rights Reserved.
MED-MSL-TD-US-0232 v2 CP-TD-US-0684 v3 10/2022

1/6

FACULTY CONTRIBUTOR

Henry Nasrallah, MD

Vice-Chair for Faculty Development and Mentorship
Professor of Psychiatry, Neurology, and Neuroscience
Director, Neuropsychiatry Program
Director, Schizophrenia Program
Department of Psychiatry and Behavioral Neuroscience
University of Cincinnati College of Medicine
Cincinnati, OH